|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0010803,
umls-concept:C0030705,
umls-concept:C0032854,
umls-concept:C0033325,
umls-concept:C0681890,
umls-concept:C0728940,
umls-concept:C1416714,
umls-concept:C1561558,
umls-concept:C1880198,
umls-concept:C2239176,
umls-concept:C2745888
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2008-6-18
|
|
pubmed:abstractText |
Cytokeratin 10 (CK10) was found to be expressed differently in human hepatocellular carcinoma (HCC) cell lines with different metastatic potentials in our previous research. The aim of this study was to assess the value of CK10 alone or in combination with cytokeratin 19 (CK19) in predicting tumor recurrence after curative resection in HCC patients.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:ChenRong-XinRX,
pubmed-author:GaoQiangQ,
pubmed-author:HeYi-ZhouYZ,
pubmed-author:JiYuanY,
pubmed-author:LeeJ SJS,
pubmed-author:LuQingQ,
pubmed-author:QinWeng-ZhenWZ,
pubmed-author:QiuShuang-JianSJ,
pubmed-author:ShiGuo-MingGM,
pubmed-author:SunHui-ChuanHC,
pubmed-author:TangZhao-YouZY,
pubmed-author:WuBingB,
pubmed-author:WuZhi-QuanZQ,
pubmed-author:YangGuo-HuanGH,
pubmed-author:YangXin-RongXR,
pubmed-author:YangXuX,
pubmed-author:YuBingB,
pubmed-author:ZhouJianJ
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3850-9
|
|
pubmed:meshHeading |
pubmed-meshheading:18559605-Adult,
pubmed-meshheading:18559605-Aged,
pubmed-meshheading:18559605-Aged, 80 and over,
pubmed-meshheading:18559605-Carcinoma, Hepatocellular,
pubmed-meshheading:18559605-Cell Line, Tumor,
pubmed-meshheading:18559605-Cohort Studies,
pubmed-meshheading:18559605-Female,
pubmed-meshheading:18559605-Follow-Up Studies,
pubmed-meshheading:18559605-Humans,
pubmed-meshheading:18559605-Keratin-10,
pubmed-meshheading:18559605-Keratin-19,
pubmed-meshheading:18559605-Liver Neoplasms,
pubmed-meshheading:18559605-Male,
pubmed-meshheading:18559605-Middle Aged,
pubmed-meshheading:18559605-Postoperative Period,
pubmed-meshheading:18559605-Prognosis,
pubmed-meshheading:18559605-Survival Analysis,
pubmed-meshheading:18559605-Tissue Array Analysis,
pubmed-meshheading:18559605-Tumor Markers, Biological
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
|
|
pubmed:affiliation |
Liver Cancer Institute, Zhong Shan Hospital and Shanghai Medical School, Fudan University, Key Laboratory for Carcinogenesis and Cancer Invasion, Chinese Ministry of Education, Shanghai Cancer Institute, Shanghai, PR China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Validation Studies
|
